Interleukin-2 and Oncolytic Virotherapy: A New Perspective in Cancer Therapy.

MLA

Aghbash, Parisa Shiri, et al. “Interleukin-2 and Oncolytic Virotherapy: A New Perspective in Cancer Therapy.” Anti-Cancer Agents in Medicinal Chemistry, vol. 23, no. 18, 2023, pp. 2008–26. EBSCOhost, https://doi.org/10.2174/1871520623666230727095154.

APA

Aghbash, P. S., Rasizadeh, R., Yari, A. H., Lahouti, S., MotieGhader, H., Nahand, J. S., Entezari-Maleki, T., & Baghi, H. B. (2023). Interleukin-2 and Oncolytic Virotherapy: A New Perspective in Cancer Therapy. Anti-Cancer Agents in Medicinal Chemistry, 23(18), 2008–2026. https://doi.org/10.2174/1871520623666230727095154

Chicago

Aghbash, Parisa Shiri, Reyhaneh Rasizadeh, Amir Hossein Yari, Shiva Lahouti, Habib MotieGhader, Javid Sadri Nahand, Taher Entezari-Maleki, and Hossein Bannazadeh Baghi. 2023. “Interleukin-2 and Oncolytic Virotherapy: A New Perspective in Cancer Therapy.” Anti-Cancer Agents in Medicinal Chemistry 23 (18): 2008–26. doi:10.2174/1871520623666230727095154.